A Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-120
SponsorPascoe Pharmazeutische Praeparate GmbH

About this trial

The goal of this observational study is to learn more about the disease and the symptoms where the product will use and in which patient groups. Further on, it is interesting to know clinical pictures, the symptoms improve. Patients with acute or chronical disease with vitamin c deficiency could be involved.

The main questions it aims to answer are:

* how do the symptoms of the disease change * how is the tolerability

Eligibility criteria

Qualifiers

Patients with vitamin C deficiency

Age ≥ 18 years

Disqualifiers

Hypersensitivity to the active ingredient or any of the excipients

Oxalate urolithiasis

Iron storage disease (thalassemia, hemochromatosis, sideroblastic anemia) or recent red blood cell transfusion

Renal insufficiency

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 2 trial groups